Novartis Pharma Ag - Jun 15, 2022 Form 3 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
10%+ Owner
Signature
Novartis Pharma AG /s/ Christian Rehm, Authorized Signatory /s/ Lukas Foertsch, Authorized Signatory
Stock symbol
DTIL
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
3
Date filed
6/27/2022, 04:38 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DTIL Common Stock 12.4M Jun 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Novartis Pharma AG is the record holder of the securities reported herein. As the parent of Novartis Pharma AG, Novartis AG is the beneficial ownership of these securities.